News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,348 Results
Type
Article (87051)
Company Profile (704)
Press Release (767579)
Multimedia
Podcasts (155)
Webinars (20)
Section
Business (232906)
Career Advice (4134)
Deals (39771)
Drug Delivery (131)
Drug Development (91147)
Employer Resources (200)
FDA (18215)
Job Trends (17374)
News (397019)
Policy (39855)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (123)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (192)
Approvals (18182)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (415)
Cancer (3280)
Cardiovascular disease (263)
Career advice (3543)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (601)
Cervical cancer (26)
Clinical research (74584)
Collaboration (1176)
Company closure (4)
Compensation (787)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (414)
Cystic fibrosis (126)
Data (3345)
Decentralized trials (2)
Denatured (55)
Depression (84)
Diabetes (390)
Diagnostics (7010)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (162)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98373)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131729)
Executive appointments (932)
FDA (20260)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1056)
Gene editing (154)
Generative AI (42)
Gene therapy (474)
GLP-1 (962)
Government (5304)
Grass and pollen (7)
Guidances (321)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (137)
Interviews (813)
IPO (17909)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (610)
Leadership (27)
Legal (10140)
Liver cancer (87)
Longevity (12)
Lung cancer (455)
Lymphoma (232)
Machine learning (16)
Management (65)
Manufacturing (497)
MASH (106)
Medical device (14771)
Medtech (14782)
Mergers & acquisitions (22634)
Metabolic disorders (1000)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2434)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (51)
Obesity (507)
Opinion (298)
Ovarian cancer (108)
Pain (134)
Pancreatic cancer (136)
Parkinson's disease (208)
Partnered (26)
Patents (350)
Patient recruitment (204)
Peanut (55)
People (65860)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23004)
Phase II (32376)
Phase III (24394)
Pipeline (2121)
Policy (262)
Postmarket research (3554)
Preclinical (10396)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (554)
Real estate (7403)
Recruiting (76)
Regulatory (27398)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (111)
Series A (176)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (98)
Vaccines (955)
Venture capital (62)
Weight loss (346)
Women's health (53)
Worklife (20)
Date
Today (162)
Last 7 days (781)
Last 30 days (2580)
Last 365 days (33852)
2025 (20887)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (285)
Arkansas (14)
Asia (50638)
Australia (8896)
California (8313)
Canada (2538)
China (761)
Colorado (355)
Connecticut (370)
Delaware (223)
Europe (116258)
Florida (1244)
Georgia (281)
Hawaii (3)
Idaho (67)
Illinois (767)
India (35)
Indiana (407)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1163)
Massachusetts (6336)
Michigan (283)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (90)
New Hampshire (75)
New Jersey (2308)
New Mexico (31)
New York (2293)
North Carolina (1294)
North Dakota (10)
Northern California (3638)
Ohio (266)
Oklahoma (17)
Oregon (48)
Pennsylvania (1775)
Puerto Rico (18)
Rhode Island (41)
South America (1654)
South Carolina (38)
South Dakota (1)
Southern California (3119)
Tennessee (136)
Texas (1275)
United States (31162)
Utah (242)
Virginia (224)
Washington D.C. (80)
Washington State (719)
West Virginia (4)
Wisconsin (89)
There are 855,348 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Performance Enhancing Drugs Market Forecast to Surpass USD 841.3 Million by 2032, Driven by Growing Demand in Competitive Sports | Coherent Market Insights
August 13, 2025
·
1 min read
Events
Resilience Through Reinvention: How Pharma is Navigating Uncertainty During Turbulent Times
Drug development is already complex, but in this regulatory landscape, risks lurk at every turn. Just us for a roundtable where our guests give their observations and recommendations on how to navigate uncertainty during turbulent times.
August 13, 2025
Press Releases
Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
August 13, 2025
·
1 min read
Press Releases
Adaptimmune Reports Q2 Financial Results and Provides Business Update
August 13, 2025
·
1 min read
Press Releases
Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
August 13, 2025
·
12 min read
Press Releases
In Vitro Diagnostics Market to Hit USD 197.06 Billion by 2032, Driven by a Surge in Chronic and Infectious Disease Burden | Coherent Market Insights
August 13, 2025
·
1 min read
Press Releases
Cell Reprogramming Market to Hit USD 715.6 Million by 2032, Driven by Growing Regenerative Medicine Demand | Coherent Market Insights
August 13, 2025
·
1 min read
Press Releases
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Conce
- Funding combines equity investment and convertible loan - Focus on best-in-class, clinical-stage peanut allergen neutralizing antibody - Further potential for developing Mabylon’s discovery and pre-clinical pipeline programs - Dr. Thomas Hecht has joined Board of Directors
August 13, 2025
·
1 min read
Press Releases
BioDlink Accelerates Global Expansion with Bevacizumab Launch in Colombia and Pakistan
August 13, 2025
·
1 min read
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic review but will eventually be let go.
August 13, 2025
·
2 min read
·
Tristan Manalac
1 of 85,535
Next
